See news from the Bioscience and Technology Business Center (BTBC), updates on our growth, news from our tenant companies and partners, and media coverage.
Governor Laura Kelly Celebrates Economic Development, Innovation at Groundbreaking for Kansas University BTBC Expansion
Oct 15, 2020 Governor Laura Kelly today applauded the announcement of the Phase III expansion of the Bioscience & Technology Business Center (BTBC) at the University of Kansas, and introduction of the new KU Innovation Park. The Phase III expansion includes a new 70,000-square-foot facility, which will feature fully functional wet labs, offices, and collaborative […]
LAWRENCE — A University of Kansas professor is leading an effort to develop a quick-turnaround COVID-19 test that can be used at home. “Eventually, our test will go into a home — like an early pregnancy test at home,” said Steven Soper, a Foundation Distinguished Professor with appointments in both the School of Engineering and […]
Preliminary Results Show TRIOLOGY® Restoring Rinse Capable of Inactivating SARS-CoV-2 with 99.92% Efficacy
For the past decade, TRIOLOGY® Restoring Rinse has been used to promote oral health and healing Independent lab testing indicates TRIOLOGY® is capable of inactivating SARS- CoV-2 (COVID-19 virus) NOWsystem, Inc. is looking to begin human testing to confirm the percentage of inactivation of the COVID-19 virus when the mouth rinse is used in the […]
Kansas-Based Company ViroVax Licenses Adjuvant to be Used in India’s First COVID-19 Vaccine in Human Trials
Kansas-based ViroVax LLC has licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International Limited, an Indian biotech company. Bharat Biotech is partnering with the Indian Council of Medical Research (ICMR) to produce India’s first COVID-19 vaccine approved for human trials, COVAXIN®, which uses ViroVax’s adjuvant technology. COVAXIN® is an inactivated vaccine derived from a strain of […]